No Data
No Data
LIFETECH SCI (01302.HK) subscribed a total of 0.273 billion yuan for a principal-protected floating yield structured deposit.
On February 27, Glorious Share announced that LIFETECH SCI (01302.HK) stated that its wholly-owned subsidiary LIFETECH Shenzhen has signed a structured deposit agreement with CM BANK for the period from June 28, 2024, to February 27, 2025. According to this agreement, LIFETECH Shenzhen will subscribe for principal-protected floating rate structured deposits issued by CM BANK, with a total principal amount of RMB 0.273 billion.
Express News | LifeTech Scientific - Unit Subscribed for Principal-Protected Structured Deposits Issued by China Merchants Bank for RMB273 Mln
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
LifeTech Scientific Corporation's (HKG:1302) 30% Jump Shows Its Popularity With Investors
LifeTech Scientific's (HKG:1302) Earnings Have Declined Over Three Years, Contributing to Shareholders 50% Loss